Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amnestic Symptoms”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Very early researchLooking for participantsNCT06538311
What this trial is testing

Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentLogopenic Progressive Aphasia+1 more
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02324153
What this trial is testing

Ramelteon in the Prevention of Post-operative Delirium

Who this might be right for
DeliriumDelirium, Dementia, Amnestic, Cognitive DisordersDelayed Emergence From Anesthesia+1 more
Johns Hopkins University 80
Large-scale testing (Phase 3)Study completedNCT01028053
What this trial is testing

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
GE Healthcare 365
Not applicableStudy completedNCT02265757
What this trial is testing

Behavioral Interventions to Prevent or Delay Dementia

Who this might be right for
Mild Cognitive ImpairmentMemory DisordersMild Dementia+6 more
Mayo Clinic 272
Not applicableStudy completedNCT01599689
What this trial is testing

Pilot and Feasibility Study of a Mirrors Intervention for Reducing Delirium in Older Cardiac Surgical Patients

Who this might be right for
Postoperative Delirium
Papworth Hospital NHS Foundation Trust 223
Large-scale testing (Phase 3)Study completedNCT01404169
What this trial is testing

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
Eisai Limited 260
Testing effectiveness (Phase 2)Study completedNCT00620191
What this trial is testing

Metformin in Amnestic Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment
Columbia University 80
Not applicableStudy completedNCT01078636
What this trial is testing

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 342
Large-scale testing (Phase 3)Ended earlyNCT01066546
What this trial is testing

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT01044758
What this trial is testing

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI)
Johns Hopkins University 96
Post-approval studies (Phase 4)Study completedNCT01951118
What this trial is testing

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDelirium, Dementia, Amnestic, Cognitive Disorders
New York State Psychiatric Institute 121
Not applicableStudy completedNCT00908999
What this trial is testing

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Who this might be right for
AnosognosiaAlzheimer's DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 60
Not applicableStudy completedNCT01482351
What this trial is testing

Mild Cognitive Impairment and Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaMild Cognitive Impairment
George Mason University 54
Testing effectiveness (Phase 2)Study completedNCT02957123
What this trial is testing

Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome

Who this might be right for
Organic Brain Syndrome, NonpsychoticNeurocognitive DisordersMental Disorder, Organic+6 more
Russian Academy of Medical Sciences 30
Not applicableLooking for participantsNCT04240561
What this trial is testing

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

Who this might be right for
Hearing Loss, SensorineuralDementia of Alzheimer TypeAmnestic Mild Cognitive Impairment
Northwestern University 20
Not applicableStudy completedNCT00512200
What this trial is testing

Postoperative Cognitive Dysfunction in Geriatric Patients

Who this might be right for
Delirium, Dementia, Amnestic, Cognitive DisordersPostoperative ComplicationsMemory Disorders
University Hospital, Basel, Switzerland 280
Not applicableLooking for participantsNCT02740634
What this trial is testing

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

Who this might be right for
Atypical Alzheimer's DiseaseLogopenic Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)+5 more
Mayo Clinic 60
Not applicableStudy completedNCT02814526
What this trial is testing

Exercise in Adults With Mild Memory Problems

Who this might be right for
Mild Cognitive ImpairmentCognitive DeclineMemory Impairment
Alzheimer's Disease Cooperative Study (ADCS) 296
Large-scale testing (Phase 3)Ended earlyNCT02783573
What this trial is testing

Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

Who this might be right for
Alzheimer's Disease
AstraZeneca 1,722
Testing effectiveness (Phase 2)Study completedNCT01276353
What this trial is testing

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Who this might be right for
Alzheimer's Type Dementia
Eisai Inc. 45
Load More Results